Featured Research
Interferon Shows No Benefit in EURAMOS-1 Trial
Adding pegylated interferon to post-surgery maintenance therapy for people with osteosarcoma showed no clear benefit beyond existing standard chemotherapy, according to recent findings from the ongoing EURAMOS-1 clinical trial.
Read More